Pretreatment with the heterocyclic compound EDU -[2-(2-oro-1-imidazoli
ndinyl)ethyl]-N'-phenylurea) has previously been shown to reduce polym
orphonuclear leukocyte (PMN) infiltration into the airways of ozone-ex
posed rats. The present study further examined the effects of 1 and 2
days EDU pretreatment on rat lung inflammatory responses by determinin
g PMN infiltration in response to intratracheal instillation with the
chemoattractant formyl-norleucine-leucine-phenylalanine (fNLP). Maxima
l recovery of PMNs by bronchoalveolar lavage was observed 4 hr after f
NLP instillation with no alteration in the numbers of recoverable macr
ophages and lymphocytes. Although 1-day pretreatment with EDU did not
affect PMN recovery from fNLP-instilled rat lungs, 2 days of EDU pretr
eatment prevented PMN infiltration as indicated by PMN recoveries that
were similar to those obtained from saline-instilled lungs. Measureme
nts of lung-marginated and interstitial pools of inflammatory cells us
ing collagenase tissue digestion demonstrated no effect of 2 days EDU
pretreatment. Although 2 days EDU pretreatment alone did not alter blo
od PMN content, lung permeability, and the lavage recoveries of inflam
matory cells, blood PMN responses to chemotactic stimuli in vitro were
impaired. In addition, EDU was shown to directly inhibit PMN chemotax
is and superoxide anion generation in vitro. These data demonstrated t
hat EDU acts by interfering with PMN activation and migration rather t
han by decreasing PMN availability. EDU, by modulating the inflammator
y response, represents a useful compound for preventing PMN-associated
amplification of acute lung injuries. (C) 1994 Academic Press, Inc.